What You Should Know:
- Pangea Biomed, a leader in precision oncology, announced a significant breakthrough in its ENLIGHT cancer response predictor. A new study published in Nature Cancer demonstrates the effectiveness of their ENLIGHT-DP platform, revealing its ability to predict cancer treatment response across various types and drugs using only routine pathology slides.
- While these findings are promising, further validation and testing are planned for regulatory
Read More
AI Ushers in New Era of Global Healthcare Equity and Efficiency
What You Should Know:
- The global healthcare landscape is undergoing a transformative shift. Digital innovation, particularly the integration of Artificial Intelligence (AI), is emerging as a powerful tool to improve access, quality, and affordability of healthcare worldwide.
- A recent white paper by the World Economic Forum, in collaboration with leading organizations, highlights the exciting potential of AI in social innovation, specifically within healthcare. The report
Read More
Cano Health Emerges from Chapter 11, Focused on Florida Market
What You Should Know:
- Cano Health, a value-based primary care provider, announced today that it has successfully exited Chapter 11 bankruptcy as a reorganized private company.
- The emergence follows a strategic restructuring aimed at improving the company's financial health and optimizing operations.
Key Achievements of the Restructuring
Debt Reduction: Cano Health significantly reduced its debt burden by converting over $1 billion of pre-bankruptcy debt into common
Read More
New Hope for Early Alzheimer’s: FDA Approves Kisunla to Slow Disease Progression
What You Should Know:
- Eli Lilly's Kisunla™ (donanemab-azbt) has been approved by the FDA as a treatment for adults in the early stages of Alzheimer's disease (AD), including those with mild cognitive impairment (MCI) and mild dementia, who have confirmed amyloid plaque buildup in the brain.
- The FDA approval marks a significant step forward in the fight against Alzheimer's, offering new hope for patients and their families.
How Kisunla Works
Kisunla targets amyloid
Read More
Hummingbird Healthcare Secures $10M to Streamline Patient Access, Create Jobs
What You Should Know:
- Hummingbird Healthcare Inc., a tech-driven healthcare services company raises $10M in Series A funding led by UCHealth, a leading Colorado-based health system and existing investor. The round also included participation from CU Healthcare Innovation Fund, 8VC, and Gaingels.
- With this new funding, Hummingbird is poised to expand its reach and empower healthcare providers to deliver exceptional patient experiences.
Focus on Patient Access and Operational
Read More
Prescribe FIT Scores $4.8M to Expand Remote Patient Monitoring for Orthopedic Care
What You Should Know:
- Prescribe FIT, a leader in remote patient monitoring (RPM) and virtual lifestyle coaching for musculoskeletal health secures $4.8M in Series A funding. The funding round includes investments from prominent figures in the healthcare and business sectors, including Jim Grote, Tamarind Hill, JobsOhio Growth Capital, seasoned executives, and orthopedic surgeons.
- The investment will fuel the company's mission to improve patient outcomes and well-being
Read More
Former Outcome Health Execs Sentenced in $1B Fraud Scheme
What You Should Know:
- Three former executives of Outcome Health, a Chicago-based health tech startup, were sentenced for their roles in a massive fraud scheme that defrauded clients, lenders, and investors of an estimated $1B.
- The case was investigated by the FBI and FDIC-OIG with assistance from the U.S. Securities and Exchange Commission. The prosecution was handled by the Department of Justice's Criminal Division's Fraud Section and the U.S. Attorney's Office for the Northern
Read More
K Health Secures $50M for AI Primary Care Platform
What You Should Know:
- K Health, a leader in AI-driven primary care raises $50M in funding led by Claure Group with participation from investors including Pablo Legorreta (founder and CEO of Royalty Pharma), and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP.
- With this new funding, K Health is poised to further scale its AI platform and expand its reach. The company's innovative approach has the potential to transform the primary
Read More
Biopharma at a Crossroads: AI Offers Key to R&D Reinvention
What You Should Know:
- A new report by Accenture, "Reinventing R&D in the Age of AI," paints a clear picture: the biopharmaceutical industry stands at a critical juncture. Companies that embrace intelligent technologies like AI and machine learning are poised to become the future's leaders, while those clinging to outdated methods risk falling behind.
- Accenture's report serves as a roadmap, offering valuable insights and practical steps for companies ready to embrace the
Read More
M&A: Alcon Acquires BELKIN Vision for $81M
What You Should Know:
- Alcon (SIX/NYSE: ALC), a company in eye care, announced today the completion of its acquisition of BELKIN Vision for a total of $81M. This strategic move strengthens Alcon's position in the glaucoma treatment landscape.
- By acquiring BELKIN Vision's DSLT technology, Alcon expands its treatment options for glaucoma patients. This minimally invasive procedure offers a new tool for physicians, with the potential to improve patient care and outcomes. With planned
Read More
